Recent 8-K filings for COAG

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 11, 2026 20:01 UTC leadership item 5.02

  Director Laura Tadvalkar resigns from Hemab Therapeutics board effective May 8, 2026

source · COAG on sec.gov